EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische StudieOpen Access

Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney Failure

Jena L Miller, Ahmet A Baschat, Anthony Johnson, Yair J Blumenfeld, Mauro H Schenone, Juliana S Gebb, Julie S Moldenhauer, Michael V Zaretsky, Ramen H Chmait, Juan M Gonzalez, Russell S Miller, Eyal Krispin und 31 weitere

JAMA · 11.08.2026 · 336 (6) · 473

DOI: 10.1001/jama.2026.8568 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift JAMA, erschienen am 11.08.2026. Verfasst von Jena L Miller und 42 weiteren Autor:innen. Beteiligte Einrichtung: Richard D. Wood Jr Center for Fetal Diagnosis and Treatment, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Amnion, Fetal Diseases, Lung, Lung Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Anhydramnios from fetal kidney failure causes lethal pulmonary hypoplasia. Serial amnioinfusions have shown promise in mitigating pulmonary disease from bilateral renal agenesis, but efficacy and safety for other causes of fetal kidney failure are unproven.

Objective

To assess the efficacy of serial amnioinfusions initiated before 26 weeks’ gestation to mitigate lethal pulmonary hypoplasia in cases of anhydramnios due to fetal kidney failure. Design, Setting, and Participants Prospective, nonrandomized clinical trial conducted at 13 US fetal therapy centers from December 2018 to February 2025. Outcomes for maternal-fetal pairs with anhydramnios before 22 weeks’ gestation due to fetal kidney failure without bilateral renal agenesis are reported; data collection for surviving infants continued until February 13, 2026. Exposure Thirty-two participants underwent serial amnioinfusions with isotonic fluid beginning before 26 weeks’ gestation. Main Outcomes and Measures The primary end point was neonatal survival for 14 days or longer with dialysis access placement. Secondary outcome measures of survival to discharge home and kidney transplant are reported.

Results

Twenty-nine of 32 participants (91%) had a live birth, with a median (IQR) gestational age at delivery of 34 weeks 1 day (31 weeks 5 days to 34 weeks 6 days). All participants delivered before 37 weeks’ gestation. No unexpected serious maternal adverse events occurred, and the most common maternal complications were preterm prelabor rupture of membranes in 19 participants (56%) and chorioamniotic separation in 10 (29%). The primary outcome occurred in 19 (65.5%) of 29 live-born neonates (95% CI, 45.7%-82.1%). Factors associated with survival to the primary outcome included receiving more amnioinfusions (median [IQR], 14 [9-18] in survivors vs 7 [4-11] in nonsurvivors; P = .01), longer time interval from first amnioinfusion to preterm prelabor rupture of membranes (63.5 [60.5-74.5] days in survivors vs 29.0 [22.0-56.0] days in nonsurvivors; P = .01), gestational age greater than 32 weeks (79% of survivors vs 38% of nonsurvivors; P = .03), and higher birth weight (2029 [1770-2250] g in survivors vs 1635 [1185-1915] g in nonsurvivors; P = .01). Fourteen live-born infants (48%) survived to hospital discharge at a median (IQR) age of 4.7 (3.4-5.7) months. Of the 11 infants surviving to date, 7 (64%) have undergone kidney transplant between ages 2 years to 5 years. Conclusions and Relevance Serial amnioinfusions mitigated lethal pulmonary hypoplasia in neonates with anhydramnios due to fetal kidney failure. Significant neonatal morbidity and mortality independent of early lung function was noted. Factors associated with survival were consistent with the Renal Anhydramnios Fetal Therapy trial’s bilateral renal agenesis cohort, suggesting common mechanistic pathways for mitigating pulmonary hypoplasia. Trial Registration ClinicalTrials.gov Identifier: NCT03101891

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmnionFetal DiseasesLungLung DiseasesOligohydramniosRenal InsufficiencyAdultFemaleHumansInfant, NewbornPregnancyGestational AgeInfusions, ParenteralKidneyProspective StudiesIsotonic SolutionsRenal DialysisKidney TransplantationPremature Rupture of Fetal MembranesFollow-Up StudiesInfantChild, PreschoolMaleTreatment Outcome

Substanzen

Isotonic Solutions

Autor:innen und Institutionen

  • Richard D. Wood Jr Center for Fetal Diagnosis and Treatment, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Center for Fetal Therapy, Department of Gynecology & Obstetrics, The Johns Hopkins University, Baltimore, Maryland.
  • The Fetal Center, Department of Obstetrics and Gynecology, University of Texas Health Center, Houston.
  • Department of Obstetrics & Gynecology, Stanford University School of Medicine, Stanford, California.
  • Department of Obstetrics and Gynecology, Division of Maternal and Fetal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Institute for Maternal Fetal Health, Nemours Children's Hospital, Wilmington, Delaware.

Förderung

  • NICHD NIH HHS

Zitieren

APA

Miller, J. L., Baschat, A. A., Johnson, A., Blumenfeld, Y. J., Schenone, M. H., Gebb, J. S., Moldenhauer, J. S., Zaretsky, M. V., Chmait, R. H., Gonzalez, J. M., Miller, R. S., Krispin, E., Shamshirsaz, A., Bligard, K. H., Kalan, A. M., Sanz Cortes, M., Moon-Grady, A. J., Bendel-Stenzel, E., Menon, S., …, & Atkinson, M. A. (2026). Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney Failure. JAMA, 336(6), 473. https://doi.org/10.1001/jama.2026.8568

Vancouver

Miller JL, Baschat AA, Johnson A, Blumenfeld YJ, Schenone MH, Gebb JS, et al. Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney Failure. JAMA. 2026;336(6):473. doi:10.1001/jama.2026.8568

BibTeX
@article{Miller2026,
  author = {Miller, Jena L and Baschat, Ahmet A and Johnson, Anthony and Blumenfeld, Yair J and Schenone, Mauro H and Gebb, Juliana S and Moldenhauer, Julie S and Zaretsky, Michael V and Chmait, Ramen H and Gonzalez, Juan M and Miller, Russell S and Krispin, Eyal and Shamshirsaz, Alireza and Bligard, Katherine H and Kalan, Amanda M and Sanz Cortes, Magdalena and Moon-Grady, Anita J and Bendel-Stenzel, Ellen and Menon, Shina and Wong, Cynthia and Grimm, Paul and Kwak, Cecilia and Gallup, Jacqueline and McKenna, Kristin J and Marron, Leah and Hanna, Christian and Tran, Cheryl L and Behrendt, Nicholas J and Galan, Henry L and Samuels, Joshua and Swinford, Rita and Keiser, Amaris M and Rosner, Mara and Kush, Michelle L and Nasr, Isam and Vasu, Samhita and Boss, Renee D and Jelin, Angie C and Thompson, Richard E and Davis, Jonathan M and Warren, Daniel S and Hanley, Daniel F and Atkinson, Meredith A},
  title = {Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney Failure},
  journal = {JAMA},
  year = {2026},
  volume = {336},
  number = {6},
  pages = {473},
  doi = {10.1001/jama.2026.8568}
}
Kostenlos starten →